60 min listen
Unavailable
Currently unavailable
TWiV 727: COVID-19 clinical update #52 with Dr. Daniel Griffin
Currently unavailable
TWiV 727: COVID-19 clinical update #52 with Dr. Daniel Griffin
ratings:
Length:
35 minutes
Released:
Mar 6, 2021
Format:
Podcast episode
Description
In COVID-19 clinical update #52, Daniel Griffin reviews differences in attack rates between children and adults, J&J vaccine phase III data, G6PD deficiency and vaccines, NIH halts convalescent plasma trial, dexamethasone in hospitalized patients, data on tocilizumab, and long COVID in children. Hosts: Daniel Griffin and Vincent Racaniello Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode SARS-CoV-2 attack rates in children and adults (Clin Inf Dis) Documents for J&J COVID-19 vaccine review (FDA) Convalescent plasma and clinical outcomes (JAMA) NIH halts convalescent plasma trial (NIH) Dexamethasone in hospitalized COVID-19 patients (NEJM) Tocilizumab in hospitalized COVID-19 patients (NEJM) Update on long COVID prevalence (UK ONS) Letters read on TWiV 727 Timestamps by Jolene. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv
Released:
Mar 6, 2021
Format:
Podcast episode
Titles in the series (100)
TWiV 1021: Nextstrain with Trevor Bedford: From ASV 2023 in Athens, Georgia, Vincent, Kathy and Brianne speak with Trevord Bedford about his career, the development of Nextstrain.org for real-time tracking of pathogen evolution, and evolution of SARS-CoV-2 from January 2020 through Omicron.... by This Week in Virology